NCT03430934View on ClinicalTrials.gov

Non-invasive Fluorescent Imaging System for Imaging Mohs Tumor

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

July 1, 2018

Primary Completion Date

August 1, 2019

Study Completion Date

August 1, 2019

Conditions
Skin Cancer
Interventions
COMBINATION_PRODUCT

NAVI mapping with Indocyanine green

Moh's tumor imaging with Indocyanine green

Trial Locations (1)

65212

University of Missouri Health Care, Columbia

All Listed Sponsors
lead

University of Missouri-Columbia

OTHER

NCT03430934 - Non-invasive Fluorescent Imaging System for Imaging Mohs Tumor | Biotech Hunter | Biotech Hunter